Uni-Bio Announces Positive Results from Osteoporosis Drug Trial

Uni-Bio Science Group announced its treatment for osteoporosis, Uni-PTH, produced a statistically significant improvement in bone mass during a Phase III clinical trial. Uni-PTH is a once-daily innovative biologic drug for osteoporosis in post-menopausal women. Uni-Bio focuses on developing drugs from therapeutic peptides. Founded in 2001, the company has a China R&D center in Dongguan, plus manufacturing centers in Beijing and Shenzhen. More details.... Stock Symbol: (HK: 690) Share this with colleagues: // //